Expressions of TRPV1 in Airway of Asthmatics (NCT02952066) | Clinical Trial Compass
WithdrawnNot Applicable
Expressions of TRPV1 in Airway of Asthmatics
Stopped: Prior to any participant enrollment, the PI opted to not move forward with the study.
United States0Started 2017-09-20
Plain-language summary
The purpose of this study is to measure the density of a temperature-sensitive protein, named TRPV1, in the airway mucosa tissue of both non-asthmatic and moderate to severe persistent asthmatic patients. This study may generate information for developing new therapeutic strategy.
Who can participate
Age range18 Years – 60 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Competent to understand informed consent
* Diagnosis of moderate to severe persistent allergic asthma.
* Clinical need for diagnostic bronchoscopy for assessment of asthmatic symptoms (e.g., to assess presence of chronic infection with non-tuberculous mycobacteria or other infectious agents as a cause for lack of asthma control) or therapeutic bronchoscopy for management of asthmatic symptoms (e.g., thermoplasty).
* Asthmatic subjects with history of positive skin test to confirm presence of allergy.
* Asthmatic subjects with pre-albuterol forced expiratory volume in the first second (FEV1) of \<70% of the predicted value.
* Non-asthmatic patients will include those patients with solitary pulmonary nodules and healthy individuals with acute lung atelectasis (e.g. airway blocked by mucus plugs or foreign object).
* Scheduled for a diagnostic or therapeutic bronchoscopy procedure.
Exclusion Criteria:
* Inability to perform pulmonary function testing
* Unstable asthma control for asthmatic subjects
* An asthma exacerbation within the past month
* History of intubation for asthma
* History of smoking
* History of prematurity
* History of any lung disease or disorder except asthma
* History of congenital or acquired heart disease
* Pregnant/lactating females
* Any serious concurrent systemic disease including but not limited to diabetes, coronary artery disease, vasculitis, etc.
* History of heart arrhythmias including supraventricular tachycardia